Molbio Diagnostics

Jump to

Temasek and MOPE-backed Molbio Diagnostics kickstarts IPO prep, aims Rs 22,000-24,000 cr valuation

Molbio Diagnostics, which is known for its molecular diagnostics platform, became Goa's first startup to hit unicorn status in September 2022
Molbio's test kits for H3N2, H1N1 will detect infections in an hour

The diagnostic kit makers said the chip-based RT-PCR test will detect and quantitatively diagnose H3N2, H1N1 in a single test with a sample-to-result time of an hour
Temasek invests $85 million in Molbio Diagnostics

Goa-based Molbio Diagnostics is known for its 'Truenat' technology -- a portable, battery-operated real-time PCR platform that can be used for testing infectious diseases, including TB, COVID-19, Hepatitis-C virus, human papillomavirus, influenza and vector-borne diseases like dengue, chikungunya and malaria.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Molbio Diagnostics

Temasek and MOPE-backed Molbio Diagnostics kickstarts IPO prep, aims Rs 22,000-24,000 cr valuation

Molbio's test kits for H3N2, H1N1 will detect infections in an hour

Temasek invests $85 million in Molbio Diagnostics